Nexgel Net Worth
Nexgel Net Worth Breakdown | NXGL |
Nexgel Net Worth Analysis
Nexgel's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Nexgel's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Nexgel's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Nexgel's net worth analysis. One common approach is to calculate Nexgel's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Nexgel's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Nexgel's net worth. This approach calculates the present value of Nexgel's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Nexgel's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Nexgel's net worth. This involves comparing Nexgel's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Nexgel's net worth relative to its peers.
Enterprise Value |
|
To determine if Nexgel is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nexgel's net worth research are outlined below:
| Nexgel Inc had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (3.16 M) with profit before overhead, payroll, taxes, and interest of 1.19 M. | |
| Nexgel Inc currently holds about 9.79 M in cash with (3.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76. | |
| Nexgel Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 3000 shares by Henry Scott Robert of Nexgel at 3.3655 subject to Rule 16b-3 |
Nexgel Quarterly Good Will |
|
Nexgel uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nexgel Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nexgel's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Nexgel's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nexgel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nexgel Inc backward and forwards among themselves. Nexgel's institutional investor refers to the entity that pools money to purchase Nexgel's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 56.8 K | Vanguard Group Inc | 2024-09-30 | 50 K | Massey, Quick & Co. Llc | 20242024-09-30 | 35.7 K | Renaissance Technologies Corp | 2024-09-30 | 28.5 K | Goss Wealth Management Llc | 2024-09-30 | 19.3 K | Ubs Group Ag | 2024-09-30 | 2.7 K | Tower Research Capital Llc | 2024-09-30 | 1.8 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.6 K | Advisor Group Holdings, Inc. | 2024-09-30 | 310 |
Follow Nexgel's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.78 M.Market Cap |
|
Project Nexgel's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.42) | (0.44) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.60) | (0.64) |
When accessing Nexgel's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Nexgel's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nexgel's profitability and make more informed investment decisions.
Evaluate Nexgel's management efficiency
Nexgel Inc has return on total asset (ROA) of (0.2316) % which means that it has lost $0.2316 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6431) %, meaning that it created substantial loss on money invested by shareholders. Nexgel's management efficiency ratios could be used to measure how well Nexgel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.35. The value of Return On Capital Employed is expected to slide to -0.44. At this time, Nexgel's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.40 this year, although the value of Total Current Assets will most likely fall to about 3.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.82 | 0.48 | |
| Tangible Book Value Per Share | 0.59 | 0.44 | |
| Enterprise Value Over EBITDA | (4.02) | (4.22) | |
| Price Book Value Ratio | 2.31 | 2.20 | |
| Enterprise Value Multiple | (4.02) | (4.22) | |
| Price Fair Value | 2.31 | 2.20 | |
| Enterprise Value | 11 M | 10.4 M |
At Nexgel Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 3.8601 | Revenue | Quarterly Revenue Growth 0.234 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexgel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexgel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nexgel insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nexgel Corporate Filings
F4 | 8th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 6th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
10Q | 19th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Nexgel Earnings per Share Projection vs Actual
When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 0.234 | Return On Assets | Return On Equity |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.